304 related articles for article (PubMed ID: 27686408)
41. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
42. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
43. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
44. Oral administration of PDX1 confers protection against insulitis in the non-obese diabetic (NOD) mice.
Lin P; Li W; Yao Z; Sun Y; Wang L; Li S; Chen L
Biochem Biophys Res Commun; 2015 Oct; 466(4):656-63. PubMed ID: 26403969
[TBL] [Abstract][Full Text] [Related]
45. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
[TBL] [Abstract][Full Text] [Related]
46. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
[TBL] [Abstract][Full Text] [Related]
47. βig-h3 Represses T-Cell Activation in Type 1 Diabetes.
Patry M; Teinturier R; Goehrig D; Zetu C; Ripoche D; Kim IS; Bertolino P; Hennino A
Diabetes; 2015 Dec; 64(12):4212-9. PubMed ID: 26470788
[TBL] [Abstract][Full Text] [Related]
48. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.
Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370
[TBL] [Abstract][Full Text] [Related]
49. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
Ogawa N; Minamimura K; Kodaka T; Maki T
J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
[TBL] [Abstract][Full Text] [Related]
50. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
51. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
52. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
53. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
54. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
[TBL] [Abstract][Full Text] [Related]
55. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
[TBL] [Abstract][Full Text] [Related]
56. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
57. The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse.
Mollah ZU; Wali J; McKenzie MD; Krishnamurthy B; Graham KL; Fynch S; Szanyi J; Santamaria P; Brodnicki T; Allison J; Strasser A; Kay TW; Thomas HE
Apoptosis; 2011 Aug; 16(8):822-30. PubMed ID: 21644000
[TBL] [Abstract][Full Text] [Related]
58. B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes.
Egia-Mendikute L; Arpa B; Rosell-Mases E; Corral-Pujol M; Carrascal J; Carrillo J; Mora C; Chapman H; Panosa A; Vives-Pi M; Stratmann T; Serreze D; Verdaguer J
Front Immunol; 2019; 10():1732. PubMed ID: 31428087
[TBL] [Abstract][Full Text] [Related]
59. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
Tisch R; Liblau RS; Yang XD; Liblau P; McDevitt HO
Diabetes; 1998 Jun; 47(6):894-9. PubMed ID: 9604865
[TBL] [Abstract][Full Text] [Related]
60. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
